Selected Publications

Simone CB, Yegya-Raman N, Manjunath S, Verma V, Shabason JE, Xu L, Cengel KA, Levin WP, Berman AT, Christodouleas JP, Aggarwal C, Cohen RB, Langer CJ, Pechet TT, Singal S, Kucharczuk JC, Rengan R, Feigenberg SJ: Prospective Feasibility and Phase I/II Trial of Preoperative Proton Beam Therapy with Concurrent Chemotherapy for Resectable Stage IIIA or Superior Sulcus Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys May 2023.

Yegya-Raman N, Berlin E, Feigenberg SJ, Ky B, Sun : Cardiovascular Toxicity and Risk Mitigation with Lung Cancer Treatment. Current Oncology Reports May 2023.

Yegya-Raman N, Jabbour SK, Feigenberg SJ: Sinoatrial Node Radiation Dose and Atrial Fibrillation in Patients With Lung Cancer. JAMA Oncol April 2023.

Natarajan J, Yegya-Raman N, Kegelman TP, Kallan MJ, Roshkovan L, Katz S, Ky B, Fradley M, Xiao Y, Lee SH, Zhang Z, Langer C, Aggarwal C, Cohen R, Cengel K, Levin W, Berman AT, Feigenberg SJ: Cardiovascular Substructure Dose and Cardiac Events following Proton-and Photon-Based Chemoradiotherapy for Non-Small Cell Lung Cancer. Advances in Radiation Oncology April 2023.

Iocolano, M., Yegya-Raman, N., Wang, X., Friedes, C., Lee, S. H., Duan, L., ... & Feigenberg, S. J. : Acute hospitalizations after proton beam therapy (PBT) versus intensity-modulated radiotherapy (IMRT) for locally advanced non–small-cell lung cancer (LA-NSCLC) in the era of immune checkpoint inhibitor (ICI) consolidation: A retrospective propensity score weighted study. Journal of Clinical Oncology April 2023.

Yegya-Raman N, Friedes C, Sun L, Iocolano M, Kim KN, Doucette A, Cohen RB, Robinson KW, Levin WP, Cengel KA, Lally B, Agarwal M, D'Avella CA, Marmarelis ME, Kosteva JA, Singh AP, Ciunci CA, Aggarwal C, Berman AT, Langer CJ, Feigenberg SJ: Utilization and Factors Precluding Receipt of Checkpoint Inhibitor Consolidation for Stage III NSCLC in a Large US Academic Health System. Clin Lung Cancer April 2023.

Friedes, Cole, Nikhil Yegya-Raman, Siqi Zhang, Michelle Iocolano, Roger B. Cohen, Charu Aggarwal, Jeffrey C. Thompson et al Feigenberg SJ: Patterns of failure in metastatic non-small cell lung cancer (mNSCLC) treated with first line pembrolizumab and use of local therapy in patients with oligoprogression. Journal of Clinical Oncology April 2023.

Kim KN, Heintz J, Yegya-Raman N, Cohen R, Kegelman T, Cengel K, Marmarelis M, Sun L, Langer C, Aggarwal C, Singh A, Singhal S, Kucharczuk J, Robinson K, Feigenberg S: Toxicities and Deaths From Intercurrent Disease Following Contemporary Postoperative Radiotherapy in Resected Non-Small-Cell Lung Cancer. Clin Lung Cancer March 2023.

Yegya-Raman N, Kegelman TP, Ho Lee S, Kallan MJ, Kim KN, Natarajan J, Deek MP, Zou W, O'Reilly SE, Zhang Z, Levin W, Cengel K, Kao G, Cohen RB, Sun LL, Langer CJ, Aggarwal C, Singh AP, O'Quinn R, Ky B, Apte A, Deasy J, Xiao Y, Berman AT, Jabbour SK, Feigenberg SJ. : Death without progression as an endpoint to describe cardiac radiation effects in locally advanced non-small cell lung cancer. Clin Transl Radiat Oncol January 2023.

Yegya-Raman N, Kegelman TP, Lee SH, Kim KN, Natarajan J, Kallan MJ, Levin WP, Cengel KA, Kao GD, Langer C, Cohen R... fEIGENBERG SJ: Association Between Cardiovascular Substructure Dose and Death Without Progression after Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics November 2022.